ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Bausch Health Companies Inc

Bausch Health Companies Inc (BVF)

7.238
0.00
( 0.00% )
Updated: 21:01:55
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
7.238
Bid
7.155
Offer
7.314
Volume
0.00
0.00 Day's Range 0.00
3.7235 52 Week Range 9.893
Previous Close
7.238
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
1,805
Financial Volume
-
VWAP
-

BVF Latest News

Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller

MOUNTAIN VIEW, Calif., Feb. 22 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced today that Mark K. Oki has been promoted to Vice President, Finance and Controller...

Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors

* Biovail Shareholders Asked to Support Two Independent Directors That are Not Tied to Management or to Eugene Melnyk * TORONTO, May 11 /PRNewswire-FirstCall/ -- Biovail Corporation (TSX, NYSE:...

GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million

RESEARCH TRIANGLE PARK, N.C., May 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE:GSK) today announced that it has entered into an agreement to divest full commercial rights to Wellbutrin...

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC Investigation of Biovail and Class Action Lawsuit HARTFORD, Conn...

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit HARTFORD, Nov. 21 /PRNewswire/ -- The November 21, 2003 edition of the Wall Street Journal...

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and Financial Reporting COLCHESTER, Conn., Nov. 21 /PRNewswire/...

/ C O R R E C T I O N -- Scott + Scott, LLC /

/ C O R R E C T I O N -- Scott + Scott, LLC / In the news release, Scott + Scott, LLC Files Securities Lawsuit Against Biovail (NYSE: BVF; TSX: BVF), issued earlier today by Scott + Scott, LLC, we...

Scott + Scott, LLC Files Securities Lawsuit Against Biovail

Scott + Scott, LLC Files Securities Lawsuit Against Biovail Pharmaceutical Company Targeted For Accounting Problems COLCHESTER, Conn., Nov. 14 /PRNewswire/ -- Scott + Scott...

Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Biovail Corporation and Others

Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Biovail Corporation and Others HARTFORD, Conn., Nov. 13 /PRNewswire/ -- A lawsuit seeking class action status has been filed in the...

Biovail Reports Third Quarter 2003 Financial Results - Correction

Biovail Reports Third Quarter 2003 Financial Results - Correction - Total revenue increased 3% for Q3 2003 versus Q3 2002 - - Total revenues increase 14% for the nine month 2003 period versus the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.204-2.741198602537.4427.627.27865717.29515242DE
40.0450.6256082302247.1937.8716.99617477.29694499DE
12-0.195-2.623436028527.4339.366.99618057.78517494DE
260.3294.76190476196.9099.363.723518606.5446644DE
52-0.622-7.913486005097.869.8933.723515827.091503DE
156-0.546-7.014388489217.7849.8933.723513637.04829508DE
260-0.546-7.014388489217.7849.8933.723513637.04829508DE

BVF - Frequently Asked Questions (FAQ)

What is the current Bausch Health Companies share price?
The current share price of Bausch Health Companies is 7.238 €
What is the 1 year trading range for Bausch Health Companies share price?
Bausch Health Companies has traded in the range of 3.7235 € to 9.893 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
E3O1Nexoptic Technology Corp
0.024 €
(41.18%)
676
QJ4Auric Minerals Corp
1.3898 €
(32.36%)
998.99k
L2QLatrobe Magnesium Ltd
0.0092 €
(29.58%)
304k
M0LYGreenland Resources Inc
0.78 €
(27.87%)
21k
G7PAEnergy Transition Minerals Ltd
0.0646 €
(27.17%)
1.02M
4XHFreeport Resources Inc
0.0135 €
(-28.95%)
10k
LL3PanGenomic Health Inc
0.1096 €
(-28.37%)
3
K1SNKlondike Silver Corporation
0.008 €
(-27.27%)
313.5k
INENIndigo Exploration Inc
0.018 €
(-25.00%)
25k
AYBAehr Test Systems Dl 01
12.105 €
(-22.65%)
3.84k
D7GNel ASA
0.19 €
(-2.81%)
9.54M
PF8European Lithium Limited
0.034 €
(14.09%)
1.66M
RQ0DWave Quantum Inc
4.381 €
(17.01%)
1.3M
G7PAEnergy Transition Minerals Ltd
0.0646 €
(27.17%)
1.02M
QJ4Auric Minerals Corp
1.3898 €
(32.36%)
998.99k

Discussion

View Full Feed
Ispro Ispro 55 seconds ago
Wanna buy back in?
FNMA
Investor2014 Investor2014 9 minutes ago
That is still the "In Press, Corrected Proof"!

What are corrected proofs?
Corrected proofs are Articles in Press that contain the author’s corrections. Final citation details (e.g., volume and/or issue number, publication year, and page numbers) still need to be added and the t
AVXL
diggitydoodle diggitydoodle 13 minutes ago
This week has started as a clone of the past 3 years. This ticker stuck at worthless, with a little up & down action to trips 1 and back down again.
Behind the scenes scenarios and predictions mean nothing...unless the news comes from the great CEO himself. But, he can't even file fins on tim
RNVA
Golden Cross Golden Cross 19 minutes ago
$ILLR Many Reasons To Like Triller Now!

~ Launch of Triller 5.0 App.
~ New Streaming Acquisition News Soon
~ Multiple Revenue Streams.
~ New CEO of Triller App is former TikTok executive Sean Kim.
~ TikTok US ban starts 1-19, 2025. Federal court just upheld
ILLR
Golden Cross Golden Cross 20 minutes ago
💎 $ILLR Many Reasons To Like Triller Now⬇️

~ Launch of Triller 5.0 App.
~ New Streaming Acquisition News Soon
~ Multiple Revenue Streams.
~ New CEO of Triller App is former TikTok executive Sean Kim.
~ TikTok US ban starts 1-19, 2025. Federal cour
ILLR
kspar1 kspar1 22 minutes ago
Wow! I had no idea the JPM conference in San Francisco is as energetic as this link reads, including the partnership announcements. Will be fun to see how Anavex is positioned. The conference supposed to generate $92M for the city.
https://www.fiercebiotech.com/biotech/jpm25-day-1-fierce-bio
JPM
Frankestin Frankestin 23 minutes ago
Truist Securities raises PT to $180 from $150 😮
The next two weeks will be eventful
AXS-07, a candidate for the acute treatment of migraines, with expectations for regulatory approval
NDA for AXS-14 for fibromyalgia... maybe yes or maybe no
AXSM
Number sleven Number sleven 27 minutes ago
https://www.courtlistener.com/docket/59859757/dr-reddys-laboratories-inc-v-amarin-pharma-inc/?page=2
Sleven,
AMRN
price_and_volume price_and_volume 31 minutes ago
"Right news" gonna get $175-350MM market cap? LOL!

Omg what a maroon.
VXIT
The Danish Dude The Danish Dude 31 minutes ago
Nice and interesting analysis, but completely irrelevant >!

I fed ChatGPT the following five comments regarding this analysis and it disagrees with you.

I saw these comments regarding how MHRA approves or rejects medecines at mhra meetings

1
NWBO
lakers17 lakers17 32 minutes ago
MTC back to $96,000 after hitting $89, 200s yesterday. Cryptos I added to in the last couple of days were BOBO, PAI, OTTO and CLUSTR. RING AI looking better. Boom or bust for me.
MTC
Golden Cross Golden Cross 35 minutes ago
Loading Zone Here! $ASII
ASII
Hi_Lo Hi_Lo 44 minutes ago
Where is the CSE press release filing?

TWOH has been halted for more than a week now and the CSE press release is still missing.

Could the run up before the halt be the problem?

Could some people have been tipped off before the run up?

Coul
TWOH
SkeBallLarry SkeBallLarry 52 minutes ago
https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/473323273_992397186268896_4170433101098362110_n.jpg?_nc_cat=100&ccb=1-7&_nc_sid=833d8c&_nc_ohc=UebR9WKXEXsQ7kNvgELlMGV&_nc_zt=23&_nc_ht=scontent-mia3-1.xx&_nc_gid=AvB9U-Cb1bfWGguzkXzMzar&oh=00_AYDqG-tA0ScuUz90hSjz11X1LQL5aezyuhOfdBXmp9pGuQ&oe=678C04
Dodger1 Dodger1 53 minutes ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175652942 I Miss Real
AABB
jondoeuk jondoeuk 56 minutes ago
NEUK201-00* is being tested in advanced/metastatic solid tumours at a single site.

https://i.postimg.cc/fyWcxcwj/download.png

* It could be an iNK with just a high-affinity non-cleavable CD16(a) receptor, but this comes from a Chinese site that has under
HPQ
marcis marcis 58 minutes ago
I was just thinking the same thing

Go bother those serial OTC stock hijackers
( we know them all well ) that’s been doing LOI mergers, asset ( no asset ) transfers for years with never a real company.
( not you Prophet, to the shills )
Save those investors
RDAR
No-Quarter No-Quarter 58 minutes ago
Good to know, thx!
LetGoodTimesRoll LetGoodTimesRoll 59 minutes ago
The criminality surrounding BLUE Sheets data is rampant...

https://www.sec.gov/newsroom/press-releases/2025-5?utm_medium=email&utm_source=govdelivery
FOXO
Seminole Red Seminole Red 59 minutes ago
https://scontent-mia3-2.xx.fbcdn.net/v/t39.30808-6/472742874_1004087688423643_1614366062036311373_n.jpg?_nc_cat=1&ccb=1-7&_nc_sid=833d8c&_nc_ohc=nfcGrMsEIhAQ7kNvgF3nw1U&_nc_zt=23&_nc_ht=scontent-mia3-2.xx&_nc_gid=AZgGdnGS_3zIT8EnJ2PY5KX&oh=00_AYA_PYWQyRmy2OxdvryhKxL8uHQSf69FZtEDZ_CZJ06VFQ&oe=678BF3D
Bubae Bubae 59 minutes ago
New shares flying everywhere from the looks of the filings. Form 144 filed on January 10th by Atlas Merchant Capital LLC intent to sell 1,241,144 shares. approximate date of sale listed as 01/10/2025. Robert E. Diamond, Triller Chairman of the Board, Chief Executive Officer of Atlas Merchant Capita
ILLR
meshcan meshcan 1 hour ago
Yes, hence I was saying the really numbers will be in a couple quarters from now, August CC will be two full quarters that we have Vyvanse sell numbers.

CC: NASDAC2020
ELTP
PlaneReflection PlaneReflection 1 hour ago
Remember when you said it won't pass $2 again?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174119656

Please say it won't pass $10 again, $30 again and it'll never be over $200. Thanks.
FNMA